8-year trends in obesity, type 2 diabetes, and glucagon-like peptide-1 (GLP-1) use in patients with obstructive sleep apnea
Burden of cancer attributable to obesity, type 2 diabetes and associated risk factors
FDA-approved options for medical weight loss now include injectable medications like Wegovy, Zepbound, Saxenda, and Mounjaro, as well as oral medications like Foundayo, Rybelsus, and Oral Wegovy
3 GLP-1RAs and NAFLD/NASH When dietary nutrients are ingested, endogenous incretins (GIP and GLP-1) activate K and L cells in the gut, which then secrete GIP and GLP-1
Studies, including a large nested case-control study within the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, found that individuals with the highest concentrations of PFOA in their blood serum were more than twice as likely to develop kidney cancer compared to those with the lowest concentrations
Its also linked to metabolic disorders such as diabetes, and has been associated with depression and potentially cancer. Could help lower risk of some cancers A recent study looked at medical records for more than 10,000 people with early-stage cancer and found that those who took GLP-1s had a significantly lower risk of their cancer spreading than those who did not
